The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer

被引:23
作者
Hou, MF
Lin, SB
Yuan, SSF
Tsai, SM
Wu, SH
Fu, OY
Hsieh, JS
Tsai, KB
Huang, TJ
Tsai, LY
机构
[1] Kaohsiung Med Univ, Sch Technol Med Sci, Dept Clin Biochem, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Dept Pathol, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Dept Surg, Kaohsiung, Taiwan
[4] Natl Taiwan Univ, Sch Med Technol, Taipei 10764, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
[6] Kaohsiung Med Univ, Dept Obstet & Gynecol, Kaohsiung, Taiwan
[7] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan
关键词
NF-kappa B factor; breast cancer; Taiwan; HER-2/neu; histological grade;
D O I
10.1016/S0009-8981(03)00196-7
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: This study investigated the role of nuclear factor-kappa B (NF-kappaB) activity in human breast cancer with overexpression of HER-2/neu oncoprotein, as well as its role on expression of different histological grades of cancer cells taken from Taiwanese breast cancer patients. Materials and methods: Specimens were collected from 82 female breast cancer patients. The HER-2/neu oncoprotein was measured by immunohistochemistry. NF-kappaB activity expression was assessed by the electrophoretic mobility shift assay, and confirmed by the supershift technique using anti-P65 antibody in both breast cancer tissue and the adjacent normal tissue. The histological grades were measured by Modified Bloom-Richardson Grading Scheme. Results: Of the 82 cancer specimens, 81 (98.7%) showed higher or equal expressions of NF-kappaB activity when compared to the adjacent normal tissue. Fifty-five cases (67.1%) had higher levels of NF-kappaB activity in the cancerous tissue than in the adjacent normal tissue (p<0.005). With regard to tumor size, steroid receptors, stages, histological types, and node status, there were no statistically significant differences in NF-kappaB activity between cancerous tissues and adjacent normal tissues. However, significantly higher expressions of NF-kappaB activity were seen in those cases with positive HER2/neu oncoprotein, poorly differentiated histological grades, high nuclear pleomorphisms, and high mitotic counts (p<0.05). Positive HER-2/neu overexpression of oncoprotein had higher NF-kappaB activity (86%) than negative overexpression (60%) (p<0.05). It has been shown that the NF-kappaB activity increases in the HER-2/neu oncoprotein overexpression in human breast cancer. Conclusion: Overexpression of HER-2/neu gene could induce NF-kappaB activity in human breast cancer cells, as has been confirmed in other research on cell lines. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 50 条
  • [11] Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer
    Witzel, I.
    Thomssen, C.
    Krenkel, S.
    Wilczak, W.
    Bubenheim, A.
    Pantel, K.
    Neumann, R.
    Jaenicke, F.
    Mueller, V.
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2006, 21 (03) : 131 - 140
  • [12] HER-2/neu overexpression in breast cancer: An immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D
    Korkolis, D
    Ardavanis, A
    Yotis, J
    Kyroudi, A
    Gorgoulis, V
    Kittas, C
    [J]. ANTICANCER RESEARCH, 2001, 21 (3C) : 2207 - 2212
  • [13] Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA)
    Corte, MD
    Rodil, JA
    Vázquez, J
    García, L
    Rodríguez, JC
    Bongera, M
    Fernández, JC
    González, LO
    Lamelas, ML
    Allende, M
    García-Muñiz, JL
    Fueyo, A
    Vizoso, FJ
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (11) : 701 - 714
  • [14] Prognostic Significance of HER-2/neu and Survival of Breast Cancer Patients Attending a Specialized Breast Clinic in Kolkata, Eastern India
    Jana, Debarshi
    Mandal, Syamsundar
    Mukhopadhyay, Madhumita
    Mitra, Debabrata
    Mukhopadhyay, Sunit K.
    Sarkar, Diptendra Kumar
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3851 - 3855
  • [15] Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA)
    Maria D. Corte
    Juan A. Rodil
    Julio Vázquez
    Lucia García
    Juan C. Rodríguez
    Miguel Bongera
    José C. Fernández
    Luis O. González
    Ma Luz Lamelas
    Maite Allende
    José L. García-Muñiz
    Antonio Fueyo
    Francisco J. Vizoso
    [J]. Journal of Cancer Research and Clinical Oncology, 2005, 131 : 701 - 714
  • [16] HER2/neu oncoprotein overexpression in epithelial ovarian cancer: Evaluation of its prevalence and prognostic significance - Clinical study
    Verri, E
    Guglielmini, P
    Puntoni, M
    Perdelli, L
    Papadia, A
    Lorenzi, P
    Rubagotti, A
    Ragni, N
    Boccardo, F
    [J]. ONCOLOGY, 2005, 68 (2-3) : 154 - 161
  • [17] Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial
    Fei Zhou
    Ning Li
    Weihua Jiang
    Zhaolai Hua
    Lin Xia
    Qingyi Wei
    Liwei Wang
    [J]. World Journal of Surgical Oncology, 10
  • [18] Longitudinal changes in serum HER-2/neu oncoprotein levels in trastuzumab-treated metastatic breast cancer patients
    Bethune-Volters, A
    Labroquere, M
    Guepratte, S
    Hacene, K
    Neumann, R
    Carney, W
    Pichon, MF
    [J]. ANTICANCER RESEARCH, 2004, 24 (2C) : 1083 - 1089
  • [19] Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial
    Zhou, Fei
    Li, Ning
    Jiang, Weihua
    Hua, Zhaolai
    Xia, Lin
    Wei, Qingyi
    Wang, Liwei
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [20] The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer
    Schippinger, W
    Regitnig, P
    Bauernhofer, T
    Ploner, F
    Hofmann, G
    Krippl, P
    Wehrschütz, M
    Lax, S
    Carney, W
    Neumann, R
    Wernecke, KD
    Samonigg, H
    [J]. ONCOLOGY REPORTS, 2004, 11 (06) : 1331 - 1336